Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by rejajon Nov 20, 2023 8:37pm
123 Views
Post# 35745587

RE:I have a 40 page LABS research / valuation report available

RE:I have a 40 page LABS research / valuation report available Firstly, thank you for taking the time to prepare such a comprehensive analysis of Labs.

I had a quick read through the information you have compiled just to get an idea of the style of reporting you are providing, and to better understand the facts you are using to come to your conclusions. 

You've definitely got a forensic type rigour with respect to getting all the pertinent details related to an investigation.  You are detailed, careful and complete. There are a number of things I knew, but forgot about  (like the Hope BC facility) - and a number of things I did not know (like the Cannabigerol antibiotic potential).

Of particular interest are the FDA guidelines Medipharm meets. Could a larger company buy them out to gain that designation, or would the larger company need to get that designation themselves?  I'm not sure about the rules associated with such a buyout.  Makes for an interesting issue that I need to look into.

Your analysis is excellent.  It covers both financial and industry trend components and gets to the heart of the fact that there is tremendous potential here with this company even without trying to hype up the story.

Of course at 7 cents this is clearly an "under the radar" stock.  At that price, understanding the difference between hype and fact makes this a compelling place for the gambling portion of one's portfolio.  (Never hurts to have a bit of fun in the market).

Thanks again for a very interesting read!





<< Previous
Bullboard Posts
Next >>